SIGLEC14 and pancreatic serous cystadenoma: The top hit associated with skin disease (PsC probands vs. controls) was within the promoter of the immune-activating receptor SIGLEC14 (sialic acid binding Ig like lectin 14), which was hypermethylated by 10% (q = 4.32x10-6) [31].